Urothelial Carcinoma Recurrent

Oncology·MeSH: Urinary Bladder Neoplasms

Prevalence

61.0 / 100K

Incidence

18.0 / 100K/yr

0 drugs in development·0 companies·4 clinical trials

Frequently asked questions

How many clinical trials target Urothelial Carcinoma Recurrent?

There are 4 clinical trials targeting Urothelial Carcinoma Recurrent tracked by BioSniper.

What is the prevalence of Urothelial Carcinoma Recurrent?

The estimated prevalence of Urothelial Carcinoma Recurrent is approximately 61.0 per 100,000 population.

Deep-dive into Urothelial Carcinoma Recurrent

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Urothelial Carcinoma Recurrent — Drugs in Development & Clinical Trials | BioSniper